On the Cutting Edge: Clinician Insights on Utilizing Innovative Medications
Clinicians who treat Alzheimer’s patients have new medications in their arsenal. What insights have they gained in treating people with these drugs? This panel will delve into their experiences, including conversations with patients and care partners, understanding the benefits and risks, managing side effects, and adapting their practices. Hear from physicians on the cutting edge of Alzheimer’s treatments. Key Question: What insights have clinicians gained in treating people with new medications?
New Technologies for Early Detection and Diagnosis of Alzheimer’s
Scaling up technologies for early detection of Alzheimer’s pathology and cognitive impairment promises to transform the global response to Alzheimer’s disease. Digital biomarkers and fluid biomarkers (ranging from cerebrospinal fluid to blood) to detect the disease are advancing rapidly in clinical practice and will enable a more simple, timely, and accurate Alzheimer’s diagnosis. Key Question: What do these tools and technologies mean for patients and their doctors?
